TRex Bio
South San Francisco, CA
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases.
trex.bioCompany Details
Founded
- 2018
Employees
- Between 20 - 100 employees
Raised
- $169,000,000
Headquarters Location
- South San Francisco, CA
Public
- No
Acquired
- No
CEO
Johnston Erwin
Founders
- Ravi Rao
Company Collections
These are collections TRex Bio is a part of. Click on the collection name to view similar companies.
TRex Bio's Industries
TRex Bio Headquarters Location
681 Gateway Blvd 4th Floor, South San Francisco, CA 94080
Total Amount Raised: $169,000,000
TRex Bio Funding Rounds
Series B
$84,000,000
Series B Investors
Delos CapitalAvego Bioscience CapitalAgent CapitalPolaris PartnersSV Health InvestorsEli Lilly & Company FoundationPfizer Venture InvestmentsAlexandria Real Estate EquitiesJohnson & Johnson InnovationSeries A
$26,000,000
Series A Investors
Polaris PartnersSV Health InvestorsEli Lilly & Company FoundationAlexandria Real Estate EquitiesPfizer Venture InvestmentsLaurion Capital ManagementJohnson & Johnson InnovationSeries A
$59,000,000
Series A Investors
Alexandria Real Estate EquitiesJohnson & Johnson Robotics and Digital SolutionsSV Health InvestorsPfizer Venture InvestmentsEli Lilly and Company
Funding info provided by Diffbot.
TRex Bio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on TRex Bio.